Establishment of new therapeutic strategy for ARDS / macrophage activation syndrome with severe COVID-19
- Funded by KAKENHI
- Total publications:0 publications
Grant number: 21K08172
Grant search
Key facts
Disease
COVID-19Start & end year
20212024Known Financial Commitments (USD)
$37,440Funder
KAKENHIPrincipal Investigator
Hirokazu Urushiyama UnspecifiedResearch Location
JapanLead Research Institution
Tokyo UniversityResearch Priority Alignment
N/A
Research Category
Clinical characterisation and management
Research Subcategory
Supportive care, processes of care and management
Special Interest Tags
N/A
Study Type
Unspecified
Clinical Trial Details
N/A
Broad Policy Alignment
Pending
Age Group
Not Applicable
Vulnerable Population
Not applicable
Occupations of Interest
Not applicable